Sterilization Equipment Market by Product and; Services
{Equipment [Heat, Low-temperature (Ozone, Formaldehyde), Filtration),
Consumables (Sterilization Indicators, Sterilants), Services (Gamma, Steam)],
End User (Hospitals, Pharma)} - Global Forecast to 2027
Sterilization
is one of the key processes in many industries, including healthcare. In the
healthcare sector, this process plays an important role in eliminating,
destroying, or killing biological entities to maintain a hygienic or sterile
environment. This process is widely used in hospitals to prevent
hospital-acquired infections. In pharmaceutical and biotechnology, the medical
device manufacturing industry maintains a sterile processing environment within
the facility during production or experiments as per the need. The entire
sterilization process has been carried as per the standards designed by various
authorities. The factors such as growing incidences of hospital-acquired
infections, the impact of COVID-19 pandemic, rising number of surgical procedures,
rising demand for sterilization in the food industry to prevent food-borne
diseases, and increasing sterilization demand in pharmaceutical and
biotechnology industries are expected to propel the sterilization equipment
market.
Furthermore,
the harmful effects of ethylene oxide and concerns regarding the safety of
reprocessed instruments may hinder the overall sterilization equipment market's
growth during the forecast period.
Download Free Research Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5141?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=22-04-2022
The outbreak of COVID-19 has increased the focus on
developing vaccine production across developing countries across Asia-Pacific,
Latin America, and the Middle East & Africa. Thus, to have proper
sterilization during vaccine production, there is a growing demand for
sterilization products. Following are the examples of vendors producing
vaccines during this pandemic:
- As
per the data from Fierce Pharma, in April 2020, Sinovac Biotech Ltd.
(China), one of many drugmakers seeking a COVID-19 vaccine, was leveraging
China's aid to help it cross the finish line. For this, the company needs
to build out a massive new facility on the government's dime. Hence, the
company plans to build vaccine production facilities on 230,000 square
feet of land to help speed the development of 100 million COVID-19 shots
per year.
- In
March 2020, CanSino Biologics Inc. (China) received regulatory approval to
conduct a Phase I trial of its recombinant novel coronavirus vaccine
(adenovirus type 5 vector) candidate. Moreover, the state-owned Wuhan
Institute of Biological Products also received government approval to move
ahead with trials.
- In
February 2020, China Technology Exchange, Beijing Zhonghua Investment Fund
Management, Biology Institute of Shandong Academy of Sciences, and
Sinotek-Advocates International Industry Development (Shenzhen) partnered
with Generex Biotechnology for the development of an Ii-Key Peptide-based
Covid-19 vaccine.
- In
March 2020, GeneOne Life Science collaborated with researchers at Houston
Methodist Hospital to develop an RNA vaccine for Covid-19.
- In
March 2020, GC Lab Cell (South Korea) is in the phase of developing cell
therapy-based treatments for COVID-19 and is expecting to begin human
trials in the second half of the year
- A
subsidiary company of the China National Nuclear Corporation (CNNC) has
started to adopt irradiation sterilization to increase protective clothing
production efficiency. With this method, it is possible to sterilize over
10,000 medical protective suits within six hours. The irradiation
sterilization mainly uses cobalt-60 and electron beams as radioactive
sources.
- The
Indian Council of Medical Research (ICMR), Center for Disease Control and
Prevention (CDC), and the National Institutes of Health (NIH) are
currently working on the co-development of three COVID-19 vaccines.
- Zydus
Cadila is working on two vaccines. Serum Institute, Biological E, Bharat
Biotech, Indian Immunologicals, and Mynvax are developing one vaccine
each.
- Mesoblast
Ltd. (Australia), a biotech company, increased its funding to USD 90
million for scaling up manufacturing and production of its Remestemcel-L
drug to treat patients with COVID-19.
- Since
February 2020, Seegene Inc (South Korea) ramped up its COVID-19 test kits
production, which helped with the country’s rapid testing measures. The
firm company sent its kits to countries in Europe and Asia and now waiting
for U.S. FDA approval.
- Bukwang
Pharmaceutical (South Korea) declared positive antiviral effects from
trials of its hepatitis B drug clevudine on COVID-19 patients in South
Korea.
Thus, such initiatives for boosting COVID-19
vaccines' production are expected to drive the sterilization equipment market
at a CAGR of 12.2% to reach USD 23.73 billion by 2027, according to Meticulous
Research.
The report includes a
competitive landscape based on an extensive assessment of the product portfolio
offerings, geographic presence, and key strategic developments adopted by
leading market players in the industry over the past four years (2017-2020).
The key players profiled in the sterilization equipment market are STERIS plc.
(U.S.), Cantel Medical Corp. (U.S.), Getinge AB (Sweden), 3M Company (U.S.),
Advanced Sterilization Products (U.S.), MMM Group (Germany), MATACHANA group
(Spain), Cardinal Health, Inc. (U.S.), Sotera Health (U.S.), and Belimed
(Switzerland).
No comments:
Post a Comment